LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION

被引：0
|
作者：
Touchette, D. [1 ]
Boyer, N. [2 ]
Atlas, S. J. [3 ]
Agboola, F. O. [4 ]
Talon, B. [1 ]
Schultz, B. [1 ]
Kumar, V. M. [4 ]
Fazioli, K. [4 ]
Fluetsch, N. [4 ]
Rind, D. [4 ]
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Chicago Hosp Med, Chicago, IL USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
[4] Inst Clin & Econ Review, Boston, MA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH16
引用
收藏
页码：S683 / S683
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES
    Hernandez, L. G.
    Li, S.
    Toro-Diaz, H.
    Zhang, Q.
    Sheehan, J.
    Le, H.
    VALUE IN HEALTH, 2019, 22 : S228 - S229
  • [2] Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States
    Ross, Eric L.
    Soeteman, Djora, I
    PSYCHIATRIC SERVICES, 2020, 71 (10) : 988 - 997
  • [3] Safety and effectiveness of nasal esketamine in treatment-resistant depression
    Cuellar Gomez, D. Z.
    Mazon Marana, I.
    Gonzalez Ruiz, M.
    Perez Hernandez, F.
    Priede Diaz, M. I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 36 - 37
  • [4] Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
    Capuzzi, Enrico
    Caldiroli, Alice
    Capellazzi, Martina
    Tagliabue, Ilaria
    Marcatili, Matteo
    Colmegna, Fabrizia
    Clerici, Massimo
    Buoli, Massimiliano
    Dakanalis, Antonios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [5] Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression
    Ranjan, R
    Meltzer, HY
    BIOLOGICAL PSYCHIATRY, 1996, 40 (04) : 253 - 258
  • [6] Cost-effectiveness of long-term psychoanalytic psychotherapy for treatment-resistant depression: RCT evidence from the Tavistock Adult Depression Study (TADS)
    Koeser, Leonardo
    Rost, Felicitas
    Gabrio, Andrea
    Booker, Thomas
    Taylor, David
    Fonagy, Peter
    Goldberg, David
    Knapp, Martin
    McCrone, Paul
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 335 : 313 - 321
  • [7] Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report
    Sobreiro, Matildes de Freitas Menezes
    Silveira, Paulo Sergio Panse
    Cavenaghi, Vitor Breseghello
    da Costa, Leandro Paulino
    de Souza, Bruno Pinatti Ferreira
    Takahashi, Rachel Emy Straus
    Starek, Renato Vianna Marotta
    Siqueira, Jose Oliveira
    Fraguas, Renerio
    PHARMACEUTICALS, 2025, 18 (02)
  • [8] Approval of esketamine for treatment-resistant depression
    Singh, Jaskaran B.
    Daly, Ella J.
    Mathews, Maju
    Fedgchin, Maggie
    Popova, Vanina
    Hough, David
    Drevets, Wayne C.
    LANCET PSYCHIATRY, 2020, 7 (03): : 232 - 235
  • [9] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [10] Intranasal esketamine for treatment-resistant depression
    Sobieraj, A.
    Wang, E.
    Kohl, P.
    Kirsch, B.
    Slapakova, L.
    Schuele, C.
    Falkai, P.
    EUROPEAN PSYCHIATRY, 2020, 63 : S117 - S117
12345